Abstract
Psychomotor agitation is excessive, repetitive, and largely purposeless motor activity driven by inner tension — pacing, fidgeting, hand-wringing, an inability to sit still. It is not a disease in itself but a transdiagnostic syndrome: a final common pathway appearing in agitated depression, mania, schizophrenia, delirium, dementia, substance intoxication and withdrawal, and medication-induced akathisia. Because the same restlessness can spring from a psychiatric state or from a medical emergency such as hypoglycaemia or hypoxia, modern practice treats agitation first as a sign to be triaged, not a diagnosis to be assumed. This article sets out what psychomotor agitation is, how its sub-types are classified, how clinicians rate its severity with validated scales, and why its stepped management — verbal de-escalation first, medication targeted at the cause second — makes it a revealing meeting point of motor control, arousal, and emotion regulation.
Keywords: psychomotor agitation, restlessness, arousal, agitated depression, de-escalation
Few clinical signs are as immediately legible, or as easy to misread, as a person who cannot keep still. The restless pacing of someone in the grip of agitation reads instantly as distress, yet it says almost nothing on its own about why. The same jittering limbs and driven movement can be the motor face of a depressive mixed state, the overflow of manic energy, the churn of a delirious brain starved of oxygen, or the specific, drug-induced torment of akathisia. Psychomotor agitation is thus a textbook example of a transdiagnostic phenomenon — a single behavioural output with many upstream causes — and the history of its study is largely the effort to measure it rigorously and to respond to it safely, without mistaking the sign for its source.
- Agitation is a syndrome, not a diagnosis. The same excessive, purposeless motor activity arises across depression, mania, psychosis, delirium, dementia, and drug effects, so it must be triaged for cause rather than assumed to be psychiatric (Nordstrom et al., 2012). - It couples a motor sign to an inner state. Agitation is observable overactivity plus subjective tension, which is why it has been both hard to define and hard to measure (Day, 1999). - It can be rated objectively. Validated scales — the RASS, the PANSS excitement component, the Overt Agitation Severity Scale, the Cohen-Mansfield Agitation Inventory — turn a vague impression into a reproducible number (Sessler et al., 2002; Kay et al., 1987). - De-escalation comes before medication. Consensus guidelines make non-coercive verbal de-escalation the first-line response, with drugs chosen for the presumed cause rather than used as blunt sedation (Richmond et al., 2012; Wilson et al., 2012). - Agitated depression is a mixed state. The restlessness of agitated depression is best understood as depressive mood co-occurring with motor and affective activation, not as simple sadness (Koukopoulos & Koukopoulos, 1999).
What Psychomotor Agitation Is
Psychomotor agitation is defined as excessive motor activity associated with a feeling of inner tension or restlessness, in which the activity is usually non-productive and repetitive — pacing, fidgeting, wringing the hands, inability to sit still, pulling or rubbing at clothing or skin. Two components are built into that definition, and both matter. The first is the motor component: observable, often continuous overactivity that an onlooker can count. The second is the subjective component: the internal sense of tension, unease, or being driven that the person reports (when they can). It is the pairing of the two that distinguishes agitation from mere busyness or from the restlessness of boredom.
That double nature is also why agitation has been notoriously slippery to pin down. In an influential critique, Day (1999) argued that psychomotor agitation was poorly defined and badly measured across the literature: investigators folded together motor overactivity, anxiety, irritability, and aggression under one word, used scales that captured different mixtures of these, and so produced findings that could not be compared. The push toward operational rating scales over the following decades was in large part a response to that charge.
Agitation sits at one pole of a continuum of motor-affective output. At the opposite pole is psychomotor retardation — the slowed movement, speech, and thought of some depressions. Between them is the ordinary, goal-directed activity of a calm person. Crucially, agitation is a matter of arousal and drive, not of coordination: it is distinct from the involuntary movement disorders (the dyskinesias) in which the problem is the control of movement itself rather than an excess of driven activity. The empirical taxonomy that underlies much of the measurement literature — aggressive behaviour, physically non-aggressive behaviour, and verbally agitated behaviour — came from careful observation of agitation in nursing-home residents, where its forms could be catalogued without the confound of a single presumed cause (Cohen-Mansfield et al., 1989).
Types of Psychomotor Agitation
In the Medical Subject Headings (MeSH) vocabulary, Psychomotor Agitation (D011595) is classified under several parent headings at once — among them Dyskinesias and Psychomotor Disorders (within the nervous-system and behavioural trees) and Aberrant Motor Behavior in Dementia — a multiple placement that itself captures agitation's position between a movement phenomenon and a behavioural-psychiatric one. The descriptor has one narrower heading beneath it.
| Type | MeSH identifier | What distinguishes it |
|---|---|---|
| Akathisia, Drug-Induced | D017109 | A specific, medication-induced form: a subjective urge to move (most often the legs) with observable restlessness, caused chiefly by antipsychotics and other dopamine-blocking drugs. Distinguished by its pharmacological cause and its characteristic lower-limb focus. |
MeSH lists only Drug-Induced Akathisia as a formal narrower descriptor; the far larger clinical families of agitation — the agitation of depression, mania, psychosis, delirium, and dementia — are not separate headings beneath Psychomotor Agitation but are indexed under their own disorders. This is a useful reminder that a classification hierarchy such as MeSH is an indexing scheme built for retrieving literature, not a theory of the phenomenon: akathisia earns its own descriptor because it has a distinct, identifiable cause, whereas the other presentations are catalogued by the disease that produces them. The clinically decisive distinction cuts a different way, and it is orthogonal to the MeSH tree — between agitation with a medical or toxic cause (hypoxia, hypoglycaemia, infection, intoxication, withdrawal) and agitation that is primarily psychiatric — because that distinction, not the indexing label, determines what must be done first (Nordstrom et al., 2012).
A Transdiagnostic Sign: The Many Faces of Agitation
What makes psychomotor agitation conceptually interesting is precisely that it is a final common pathway. The same behaviour marks several very different states:
- In mood disorders, agitation appears in mania and, more subtly, in agitated depression. Koukopoulos & Koukopoulos (1999) reframed agitated depression not as ordinary low mood with added restlessness but as a mixed affective state — depressive content co-occurring with motor and inner activation — a view that reshaped how clinicians read restlessness in a depressed patient and warned against treating it as simple melancholia. - In schizophrenia and other psychoses, agitation is part of the excitement dimension, which is why it is captured by the excitement component of the Positive and Negative Syndrome Scale (Kay et al., 1987). - In delirium and dementia, agitation is often the presenting behavioural disturbance, and it is here — in a fluctuating, medically driven confusional state — that mistaking agitation for a psychiatric problem is most dangerous (Cohen-Mansfield et al., 1989). - In medical and toxic states, agitation can be the first visible sign of hypoxia, hypoglycaemia, sepsis, head injury, or drug intoxication and withdrawal. The emergency-psychiatry consensus is explicit that these must be actively excluded, because a reversible medical cause demands a medical, not a sedative, response (Nordstrom et al., 2012; Gottlieb et al., 2018).
The practical upshot is a reversal of intuition. Because agitation is a sign and not a diagnosis, the first question is never 'which psychiatric disorder is this?' but 'is this brain in medical trouble?' Only once a dangerous medical cause has been considered does the differential narrow to the psychiatric states in which agitation is common.
Assessing and Rating Agitation
Day's charge that agitation was badly measured drove the development and validation of rating scales that make severity reproducible (Day, 1999; Zeller & Rhoades, 2010). Several are now standard, each suited to a different setting:
- The Richmond Agitation-Sedation Scale (RASS) is a single ten-point ordinal scale running from +4 (combative) through 0 (alert and calm) down to −5 (unarousable). Devised for intensive care, it is quick, has excellent inter-rater reliability, and captures both agitation and over-sedation on one axis (Sessler et al., 2002). - The PANSS excitement component (PANSS-EC) sums five items from the Positive and Negative Syndrome Scale — excitement, tension, hostility, uncooperativeness, and poor impulse control — each rated 1-7, giving a score from 5 to 35. It is the workhorse agitation outcome in psychosis trials (Kay et al., 1987). - The Overt Agitation Severity Scale (OASS) counts discrete agitated behaviours (such as repetitive movements or vocalisations) and weights them by frequency, giving an observational measure that does not depend on the patient's self-report (Yudofsky et al., 1997). - The Cohen-Mansfield Agitation Inventory (CMAI) rates the frequency of a catalogue of agitated behaviours and is the reference instrument for agitation in dementia and long-term care (Cohen-Mansfield et al., 1989).
These instruments are not interchangeable: RASS prizes speed and a single arousal axis; PANSS-EC embeds agitation within a psychosis framework; OASS and CMAI emphasise countable behaviours. A systematic review of assessment measures and treatments found this proliferation both a strength (a scale for every setting) and a weakness (results that are hard to pool), echoing Day's original complaint (Zeller & Rhoades, 2010).
Managing Agitation: De-escalation First
The modern management of acute agitation inverts the old reflex to sedate or restrain. The American Association for Emergency Psychiatry's Project BETA (Best practices in Evaluation and Treatment of Agitation) codified a stepped approach whose first line is non-coercive verbal de-escalation — a structured set of techniques (respecting personal space, not provoking, establishing verbal contact, being concise, identifying wants and feelings, listening, agreeing, setting limits, offering choices, debriefing) aimed at helping the agitated person regain self-control before any physical intervention (Richmond et al., 2012). The guiding aim, in the consensus's own framing, is to calm, not sedate: a patient who can be talked down retains dignity, autonomy, and the capacity to give a history.
When medication is needed, the consensus is that it should target the presumed cause rather than simply knock the patient out, and that it is an adjunct to de-escalation, not a replacement for it (Wilson et al., 2012). The pharmacological choices — benzodiazepines for substance-related or undifferentiated agitation, antipsychotics where psychosis is driving it, and combinations in severe cases — rest on a substantial evidence base for the acute setting (Battaglia, 2005). International and national guidelines have since converged on the same stepped logic: assess for medical cause, de-escalate verbally, offer oral medication collaboratively before resorting to parenteral, and reserve physical restraint for imminent danger (Garriga et al., 2016; Vieta et al., 2017; Baldacara et al., 2019).
Where does the patient sit on one axis?
The Richmond Agitation-Sedation Scale (RASS) puts agitation and over-sedation on a single ten-point axis, with alert-and-calm at zero. Slide through the levels and watch the zone change.
Agitated — frequent non-purposeful movement
The therapeutic target is the calm midpoint (0), not maximal sedation — the same instrument flags both poles (after Sessler et al., 2002).
Is this brain in medical trouble?
Because agitation is a transdiagnostic sign, the first question is never “which psychiatric disorder?” but “is a medical emergency driving this?” Toggle the findings.
Any single medical red flag outranks a psychiatric history — a reversible cause demands a medical, not a sedative, response (after Nordstrom et al., 2012).
Score agitation with the PANSS-EC
The PANSS excitement component sums five items, each rated 1 (absent) to 7 (extreme), giving a total from 5 to 35. Set each item and watch the total, the proportional severity, and the entry threshold update.
Total 21 — at or above the PANSS-EC ≥ 14 threshold often used to define clinically significant agitation.
A ≥ 40% fall from baseline is a frequently used marker of meaningful response (after Kay et al., 1987).
Figure
Figure 1
The agitation-sedation continuum as a single arousal axis
Worked Example
How is a patient's agitation turned into a number a trial can use? The most common instrument in psychosis research is the PANSS excitement component (PANSS-EC), which sums five items — excitement, tension, hostility, uncooperativeness, and poor impulse control — each rated from 1 (absent) to 7 (extreme) (Kay et al., 1987). The score therefore ranges from a floor of 5 × 1 = 5 to a ceiling of 5 × 7 = 35.
Consider a patient rated: excitement 5, tension 4, hostility 5, uncooperativeness 3, and poor impulse control 4. The PANSS-EC total is:
5 + 4 + 5 + 3 + 4 = 21.
To place that on the scale, express it as a proportion of the usable range (the 5-point floor is not 'zero agitation' but the minimum the instrument can record): (21 − 5) / (35 − 5) = 16 / 30 ≈ 0.53, so this patient sits just above the midpoint of the PANSS-EC range — clinically, moderate-to-marked agitation. A common trial threshold for 'clinically significant' agitation is a PANSS-EC of ≥ 14; a frequently used marker of meaningful response is a ≥ 40% reduction from baseline. A fall from 21 to, say, 11 is a (21 − 11) / 21 ≈ 48% reduction — above the 40% response threshold, and back below the 14-point entry criterion. The PanssEcDemo lets the reader set each of the five item scores and watch the total, the proportional severity, and the response threshold update.
Discussion
The study of psychomotor agitation is a case study in disciplining a vague clinical impression into a measurable, manageable sign. Day's (1999) critique — that the construct was poorly defined and badly measured — marks the turning point: before it, agitation was a word that meant subtly different things to every investigator; after it, the field invested in operational scales (RASS, PANSS-EC, OASS, CMAI) that at least make explicit what is being counted, even if they still count somewhat different things (Sessler et al., 2002; Zeller & Rhoades, 2010).
The second major shift is in management, and it runs in a humane direction. The Project BETA consensus and the guidelines that followed replaced reflexive restraint and sedation with a stepped model in which verbal de-escalation leads and medication is targeted and collaborative (Richmond et al., 2012; Wilson et al., 2012; Garriga et al., 2016). Underlying both shifts is the recognition that agitation is transdiagnostic — a final common pathway whose safe handling depends on resisting the urge to name its cause prematurely, and on excluding the medical emergencies that can hide behind it (Nordstrom et al., 2012; Gottlieb et al., 2018).
Cognitive and Psychological Implications
Agitation is not a cognitive process, but it is the behavioural overflow of several. At its core it is a disorder of arousal regulation: an excess of the same activation that, in measured amounts, mobilises attention and action. Its tie to arousal places it within the psychophysiology of the activated nervous system, and its mirror relationship with psychomotor retardation locates both on a single axis of motor-affective drive that bridges mood and movement. The restlessness of agitated depression, read as a mixed state, shows how affect and motor output are coupled rather than independent — depressive content can ride on an activated, not a slowed, motor system (Koukopoulos & Koukopoulos, 1999).
Agitation also throws emotional regulation into relief by showing what happens at its limit. Verbal de-escalation works, when it works, by lending the agitated person external regulatory structure — a calm voice, clear choices, reduced provocation — until their own capacity for self-regulation can re-engage (Richmond et al., 2012). In that sense the de-escalation protocol is applied affective science: a stepwise scaffolding of a temporarily overwhelmed control system. And because agitation surfaces in schizophrenia, bipolar disorder, and delirium alike, it is a standing reminder that very different disturbances of cognition can converge on the same motor signature — and that the signature itself, carefully measured, is clinically informative even when its cause is not yet known.
Current Directions
Three threads dominate the recent literature. The first is consensus and standardisation: the 2016 international expert consensus and subsequent management protocols have worked to harmonise definitions, assessment, and the stepped de-escalation-first pathway across countries and settings, so that agitation is handled consistently rather than idiosyncratically (Garriga et al., 2016; Vieta et al., 2017; Baldacara et al., 2019). The second is epidemiology in the real world: studies such as the STAGE survey of acute agitation across European psychiatric emergencies are quantifying how often agitation presents, how it is currently managed, and where practice diverges from guideline (San et al., 2016). The third is the medical front door: emergency-medicine frameworks increasingly emphasise the rapid exclusion of life-threatening medical causes and the least-restrictive effective intervention, pulling agitation research toward the interface of emergency medicine and psychiatry rather than treating it as a purely psychiatric concern (Gottlieb et al., 2018; Nordstrom et al., 2012). Across all three, the open question is the same one Day raised: how to measure a two-component, transdiagnostic sign well enough that findings from one setting transfer to another.
Common Misconceptions
- Agitation is a psychiatric diagnosis.
- It is a transdiagnostic sign, not a diagnosis. The identical restlessness can signal a medical emergency (hypoxia, hypoglycaemia, intoxication) or a psychiatric state, which is why cause must be triaged before it is assumed (Nordstrom et al., 2012).
- The first response should be sedation or restraint.
- Consensus guidelines make non-coercive verbal de-escalation the first line, aiming to calm rather than sedate; medication is an adjunct targeted at the cause, and restraint is reserved for imminent danger (Richmond et al., 2012; Wilson et al., 2012).
- Agitated depression is just ordinary depression with restlessness.
- It is better understood as a mixed affective state — depressive content co-occurring with motor and inner activation — with distinct implications for treatment (Koukopoulos & Koukopoulos, 1999).
- All restlessness is the same thing.
- Drug-induced akathisia is a specific, pharmacologically caused form with a characteristic urge to move the legs; it must be distinguished from the agitation of a mood, psychotic, or medical state because its treatment differs (Day, 1999).
Glossary
- Agitated depression.
- A depressive presentation dominated by restlessness and inner tension rather than slowing; now generally read as a mixed affective state.
- Akathisia.
- A subjective urge to move, usually the legs, with observable restlessness; most often induced by antipsychotic and other dopamine-blocking drugs.
- Arousal.
- The level of physiological and psychological activation of the nervous system; agitation is a state of excessive arousal expressed in motor activity.
- Cohen-Mansfield Agitation Inventory (CMAI).
- A frequency-rating instrument cataloguing agitated behaviours, the reference measure for agitation in dementia and long-term care.
- De-escalation.
- A structured set of non-coercive verbal and behavioural techniques for helping an agitated person regain self-control, used as the first-line intervention.
- Delirium.
- An acute, fluctuating disturbance of attention and awareness from a medical cause, in which agitation is a common behavioural sign.
- Dyskinesia.
- A disorder of movement control (involuntary movements); distinct from agitation, which is an excess of driven, purposeless activity rather than a control failure.
- Mixed state.
- A mood episode in which depressive and activated (manic or hypomanic) features co-occur, as in agitated depression.
- Overt Agitation Severity Scale (OASS).
- An observational instrument that counts discrete agitated behaviours and weights them by frequency, independent of self-report.
- PANSS excitement component (PANSS-EC).
- The five-item (excitement, tension, hostility, uncooperativeness, poor impulse control) agitation subscale of the Positive and Negative Syndrome Scale, scored 5-35.
- Psychomotor agitation.
- Excessive, repetitive, non-productive motor activity associated with inner tension or restlessness.
- Psychomotor retardation.
- The opposite pole: a slowing of movement, speech, and thought, seen in some depressions.
- Richmond Agitation-Sedation Scale (RASS).
- A ten-point ordinal scale from +4 (combative) to -5 (unarousable) with 0 as alert and calm, rating agitation and sedation on one axis.
- Transdiagnostic.
- Occurring across many distinct diagnoses rather than being specific to one; agitation is a transdiagnostic sign.
- Verbal de-escalation.
- The specific first-line technique of talking an agitated person down through respect, clear communication, and offered choices, aiming to calm rather than sedate.
Key Researchers
Leslie Citrome
(contemporary). Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College; a prolific author on the pharmacological treatment of agitation and on number-needed-to-treat methodology for comparing acute treatments. ORCID - Google Scholar
Marina Garriga
(contemporary). Psychiatrist at the Hospital Clínic de Barcelona; lead author of the 2016 international expert consensus on the assessment and management of agitation in psychiatry. ORCID - Faculty
Eduard Vieta
(contemporary). Professor of Psychiatry at the University of Barcelona and head of the bipolar and depressive disorders unit at the Hospital Clínic; senior author on the agitation consensus and on stepped management protocols. ORCID - Wikipedia - Google Scholar - Faculty
Scott L. Zeller
(contemporary). Vice President of Acute Psychiatry at Vituity and a leader of the American Association for Emergency Psychiatry Project BETA consensus; originator of the emergency-psychiatry principle of calming rather than sedating the agitated patient. Faculty
Frequently Asked Questions
What is psychomotor agitation in simple terms?
Psychomotor agitation is excessive, repetitive, and usually purposeless physical movement driven by a feeling of inner tension, such as pacing, fidgeting, hand-wringing, and an inability to sit still. It combines something observable (the overactivity) with something the person feels (the restlessness or unease), and it can appear in many different conditions rather than being a single illness (Day, 1999).
What causes psychomotor agitation?
Many things, which is the point: it is a transdiagnostic sign. It appears in agitated depression, mania, schizophrenia, delirium, and dementia, and it can be the first sign of a medical emergency such as low blood sugar, low oxygen, infection, or drug intoxication and withdrawal. It can also be a specific drug side-effect (akathisia). Because the causes are so varied, the cause must be worked out rather than assumed (Nordstrom et al., 2012).
How is agitation measured?
With validated rating scales suited to different settings: the Richmond Agitation-Sedation Scale (RASS) rates it from +4 to -5 on one quick axis; the PANSS excitement component sums five items for a 5-35 score in psychosis; the Overt Agitation Severity Scale counts observed behaviours; and the Cohen-Mansfield Agitation Inventory is the standard for agitation in dementia (Sessler et al., 2002; Kay et al., 1987; Cohen-Mansfield et al., 1989).
What is the difference between agitation and akathisia?
Agitation is a broad sign of excessive, tension-driven movement with many causes. Akathisia is a specific, medication-induced form, a subjective urge to move, most often the legs, caused chiefly by antipsychotics and other dopamine-blocking drugs. Telling them apart matters because akathisia is treated by adjusting the offending drug (Day, 1999).
How should an agitated person be helped?
Current guidelines put non-coercive verbal de-escalation first: respecting personal space, communicating calmly and concisely, listening, and offering choices, with the aim of calming rather than sedating. Medication is used as an adjunct, chosen for the likely cause, and physical restraint is reserved for imminent danger (Richmond et al., 2012; Wilson et al., 2012).
Why is it dangerous to assume agitation is psychiatric?
Because a reversible medical emergency (hypoxia, hypoglycaemia, sepsis, head injury, intoxication) can present as agitation, and sedating such a patient without investigating can be harmful or fatal. The emergency consensus is to actively exclude medical causes first (Nordstrom et al., 2012; Gottlieb et al., 2018).
What is agitated depression?
Agitated depression is a depressive state dominated by restlessness and inner tension rather than by slowing. It is now generally understood as a mixed affective state, in which depressive mood co-occurs with motor and emotional activation, a distinction that affects how it is treated (Koukopoulos & Koukopoulos, 1999).
How does agitation relate to cognitive psychology?
Agitation is a disorder of arousal regulation and the behavioural overflow of overwhelmed emotion regulation. It sits on a single motor-affective axis opposite psychomotor retardation, links movement to mood, and makes verbal de-escalation a kind of applied affective science: an external scaffold for a temporarily overwhelmed self-control system (Koukopoulos & Koukopoulos, 1999; Richmond et al., 2012).
References
Baldaçara, L., Ismael, F., Leite, V., Pereira, L. A., dos Santos, R. M., Gomes Júnior, V. P., Calfat, E. L. B., Diaz, A. P., Périco, C. A. M., Porto, D. M., Zacharias, C. E. K., Cordeiro, Q., da Silva, A. G., & Tung, T. C. (2019). Brazilian guidelines for the management of psychomotor agitation. Part 1. Non-pharmacological approach. Brazilian Journal of Psychiatry, 41(2), 153-167. https://doi.org/10.1590/1516-4446-2018-0163
Battaglia, J. (2005). Pharmacological management of acute agitation. Drugs, 65(9), 1207-1222. https://doi.org/10.2165/00003495-200565090-00003
Cohen-Mansfield, J., Marx, M. S., & Rosenthal, A. S. (1989). A description of agitation in a nursing home. Journal of Gerontology, 44(3), M77-M84. https://doi.org/10.1093/geronj/44.3.M77
Day, R. K. (1999). Psychomotor agitation: poorly defined and badly measured. Journal of Affective Disorders, 55(2-3), 89-98. https://doi.org/10.1016/S0165-0327(99)00010-5
Garriga, M., Pacchiarotti, I., Kasper, S., Zeller, S. L., Allen, M. H., Vázquez, G., Baldaçara, L., San, L., McAllister-Williams, R. H., Fountoulakis, K. N., Courtet, P., Naber, D., Chan, E. W., Fagiolini, A., Möller, H. J., Grunze, H., Llorca, P. M., Jaffe, R. L., Yatham, L. N., ... Vieta, E. (2016). Assessment and management of agitation in psychiatry: Expert consensus. The World Journal of Biological Psychiatry, 17(2), 86-128. https://doi.org/10.3109/15622975.2015.1132007
Gottlieb, M., Long, B., & Koyfman, A. (2018). Approach to the agitated emergency department patient. The Journal of Emergency Medicine, 54(4), 447-457. https://doi.org/10.1016/j.jemermed.2017.12.049
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2), 261-276. https://doi.org/10.1093/schbul/13.2.261
Koukopoulos, A., & Koukopoulos, A. (1999). Agitated depression as a mixed state and the problem of melancholia. Psychiatric Clinics of North America, 22(3), 547-564. https://doi.org/10.1016/S0193-953X(05)70095-2
Nordstrom, K., Zun, L. S., Wilson, M. P., Stiebel, V., Ng, A. T., Bregman, B., & Anderson, E. L. (2012). Medical evaluation and triage of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA Medical Evaluation Workgroup. Western Journal of Emergency Medicine, 13(1), 3-10. https://doi.org/10.5811/westjem.2011.9.6863
Richmond, J. S., Berlin, J. S., Fishkind, A. B., Holloman, G. H., Zeller, S. L., Wilson, M. P., Rifai, M. A., & Ng, A. T. (2012). Verbal de-escalation of the agitated patient: consensus statement of the American Association for Emergency Psychiatry Project BETA De-escalation Workgroup. Western Journal of Emergency Medicine, 13(1), 17-25. https://doi.org/10.5811/westjem.2011.9.6864
San, L., Marksteiner, J., Zwanzger, P., Figuero, M. A., Romero, F. T., Kyropoulos, G., Peixoto, A. B., Chirita, R., & Boldeanu, A. (2016). State of acute agitation at psychiatric emergencies in Europe: The STAGE study. Clinical Practice and Epidemiology in Mental Health, 12, 75-86. https://doi.org/10.2174/1745017901612010075
Sessler, C. N., Gosnell, M. S., Grap, M. J., Brophy, G. M., O'Neal, P. V., Keane, K. A., Tesoro, E. P., & Elswick, R. K. (2002). The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. American Journal of Respiratory and Critical Care Medicine, 166(10), 1338-1344. https://doi.org/10.1164/rccm.2107138
Vieta, E., Garriga, M., Cardete, L., Bernardo, M., Lombraña, M., Blanch, J., Catalán, R., Vázquez, M., Soler, V., Ortuño, N., & Martínez-Arán, A. (2017). Protocol for the management of psychiatric patients with psychomotor agitation. BMC Psychiatry, 17(1), 328. https://doi.org/10.1186/s12888-017-1490-0
Wilson, M. P., Pepper, D., Currier, G. W., Holloman, G. H., & Feifel, D. (2012). The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup. Western Journal of Emergency Medicine, 13(1), 26-34. https://doi.org/10.5811/westjem.2011.9.6866
Yudofsky, S. C., Kopecky, H. J., Kunik, M., Silver, J. M., & Endicott, J. (1997). The Overt Agitation Severity Scale for the objective rating of agitation. The Journal of Neuropsychiatry and Clinical Neurosciences, 9(4), 541-548. https://doi.org/10.1176/jnp.9.4.541
Zeller, S. L., & Rhoades, R. W. (2010). Systematic reviews of assessment measures and pharmacologic treatments for agitation. Clinical Therapeutics, 32(3), 403-425. https://doi.org/10.1016/j.clinthera.2010.03.006